Methylisothiazolinone

We are Methylisothiazolinone CAS:2682-20-4/26172-55-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Synonyms:
Methylisothiazolinone
2-methyl-2H-isothiazol-3-one
2-Methyl-4-Isothiazolin-3-one
METHYLISOTHIAZOLIN
2-Methyl-3(2H)-isothiazolone
2-METHYLISOTHIAZOLINONE
METHYLISOTHIAZOLINE
2-methylisothiazolone
2-methylisothiazolin-3-one
METHYLISOTHIAZDINONE
Skycide 100
METHYLISOTHIAZOLONE
KATHONCG
methylisothiazolin-3-one
N-methyl-isothiazole-HCl
2-Methylisothiazol-3(2H)-one
Isothiazolone,2-methyl
MIT
2-Methyl-4-isothiazoline-3-one
2-methyl-3-isothiazolone
 
Molecular Formula:  C4H5NOS
Molecular Weight:  115.15400
 
 
 
Appearance and properties: white to yellow powder
Density: 1.25 (14% aq.)
Boiling point: 182.8ºC at 760 mmHg
Melting point: 254-256 °C(lit.)
Flash point: 64.3ºC

Items of Analysis Standard of Analysis Test Results
Appearance Clear,yellow or yellow-green solution Conform
Chromaticity ≤3 1
MIT 3-5% 3.644%
CMIT 10-12% 10.734%
DCMIT ≤0.05% 0.007%
Total Active ingredient 14-14.5% 14.378%
CMIT / MIT 2.5-3.4% 2.94%
pH 2.4-4.0 2.54
Density(20) 1.26-1.32 g/cm3 1.295 g/cm3
Conclusion Conforms to Factory Standard
 


Methylisothiazolinone


Related News: In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.Cytidine 5'-monophosphate disodium salt A key publication in a preclinical model demonstrated rigosertib’s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: “A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.” Cell 165, 643).(2,6-diethyl-phenyl)-(4,5-dihydro-3H-pyrrol-2-yl)-amine Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.(2S)-2-(diethylaminomethyl)-1,4-benzodioxane Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities.Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities.

Related Products
Product Name
2-ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate View Details
1-(2,5-dimethylthiophen-3-yl)ethanone View Details
2′,3′-O-Isopropylideneadenosine View Details
Nucleating Agent N11 manufacturer 1-Hydroxy-cyclopentyl phenyl ketone manufacturer 5-bromopyridine-3-carbonitrile manufacturer 1-Bromo-2,6-difluorobenzene manufacturer 3-Chloropropyltrichlorosilane manufacturer